Patel explores how automation and AI are accelerating speed-to-therapy within hub services, the strategic implications of ConnectiveRx's expanded dispensing pharmacy capabilities, and the dominant ...
Vera Pomerantseva, Director of Product Management for RBQM, eClinical Solutions, touched on AI's growing role in clinical ...
New technologies are impacting the speed-to-therapy within hub services. In a conversation with Pharmaceutical Executive, Shivani Patel, Senior Director of Business Development at ConnectiveRx, ...
The court found ACIP member replacements were executed without required FACA processes, undermining transparency, balanced representation, and public participation in federal vaccine advisory work. A ...
PE: Can broad LLMs and smaller, focused LLMs coexist? Rusher: I think they’ll coalesce. It’s already happening where there’s very specific versions of certain LLMs for pharmaceutical research. They ...
Closed, agency-only AI platforms that cannot integrate into enterprise ecosystems face vendor-lock risk and likely attrition as clients standardize on hyperscaler-aligned architectures. CMOs should ...
Jiang Li, CEO of Vivalink, continues his conversation with Pharmaceutical Executive, this time discussing the impact of continuous monitoring on patient adherence. Clinical trials continue to ...
A growing cohort without protective immunity, combined with measles’ high basic transmissibility, enables rapid propagation even from small pockets of under-vaccination. Loss of elimination status ...
How are the Rare Disease Evidence Principles (RDEP) reshaping evidentiary expectations? Laksheeta Johari: This is a very exciting time in the rare diseas ...
In today's Pharmaceutical Executive Daily, ongoing conflict in the Middle East is straining pharmaceutical supply routes to ...
However, in the glass box approach, the raw and timestamped data (such as physiological signals like ECG, temperature, or ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results